HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure

Okami Medical Announces Closing Of $32.5M Financing

Arineta Expands Cardiac Care in Georgia with Installation of Advanced SpotLight™ Duo Scanner at PACE

New Category I CPT codes announced for treating heart failure with implantable Barostim device

Key steps to implementing a successful PET program

The Genitals Are a Window Into Health: Sex as a Vital Sign

Provident Healthcare Partners Advises Birmingham Heart Clinic in its Partnership with U.S. Heart & Vascular

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

ASA Releases New Primary Stroke Prevention Guideline

Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial